Apellis Pharmaceuticals, Inc. (APLS)
24.70
+0.92
(+3.85%)
USD |
NASDAQ |
Dec 10, 16:00
24.68
-0.01
(-0.04%)
After-Hours: 17:45
Apellis Pharmaceuticals Price: 24.70 for Dec. 10, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 177.47 |
| Amicus Therapeutics, Inc. | 9.85 |
| Fortress Biotech, Inc. | 2.95 |
| Ultragenyx Pharmaceutical, Inc. | 35.98 |
| Fulcrum Therapeutics, Inc. | 13.82 |
Price Related Metrics
| PE Ratio | 83.15 |
| PS Ratio | 3.074 |
| Price to Book Value | 7.789 |
| Price to Free Cash Flow | 39.73 |
| Earnings Yield | 1.20% |
| Market Cap | 3.125B |
| Operating PE Ratio | 38.86 |
| Normalized PE Ratio | 83.15 |